Podcasts about ARPA

El mundo está cambiando. ¿Hacia dónde vamos? En los últimos años, estados Unidos y China se han convertido en los dos grandes polos del planeta. Mientras, Rusia se está convirtiendo en una de las grandes amenazas para la estabilidad mundial. ¿Qué papel juega Europa en la nueva realidad? Arancha González Laya, que fuera Ministra de Asuntos Exteriores, aborda este mundo que camina hacia la distopia en su libro Solos en el mundo (Arpa).

Xavier Prats es experto en asuntos europeos y exdirector general de Educación, Cultura, Salud y Seguridad Alimentaria de la Comisión Europea. En esta conversación reflexiona sobre el papel de la Unión Europea en un mundo cada vez más inestable y polarizado, y analiza los desafíos que afrontan las democracias occidentales para sostener sus instituciones, su modelo social y su capacidad de imaginar el futuro. A partir de su experiencia en Bruselas, explica cómo funciona realmente la Comisión Europea, qué papel desempeñan los altos funcionarios y por qué el proyecto europeo sigue siendo una de las experiencias de cooperación política más ambiciosas de la historia contemporánea.A lo largo de la charla se habla de Erasmus y del futuro de la educación en una sociedad marcada por el cambio tecnológico y la incertidumbre. Prats reflexiona sobre la crisis de los sistemas educativos, la pérdida de prestigio de los profesores y la dificultad de preparar a las nuevas generaciones para un mundo que cambia más rápido que las instituciones encargadas de formarlas. También se aborda el Brexit, el auge del populismo, la desigualdad económica, la defensa europea y las diferencias entre el modelo social europeo y el estadounidense, especialmente en ámbitos como la sanidad pública o el Estado del bienestar.La conversación termina con una reflexión sobre los límites de la imaginación política contemporánea. Frente a una sociedad que parece incapaz de pensar alternativas al modelo actual, Prats reivindica el valor de las instituciones, la cooperación y la acción colectiva como herramientas para afrontar los grandes retos del siglo XXI. Desde la educación hasta la inteligencia artificial, pasando por la democracia y la construcción europea, defiende que el futuro no está escrito y que las sociedades democráticas conservan todavía la capacidad de decidir qué mundo quieren construir.Capítulos00:00 Introducción01:21 Cómo funciona realmente la Comisión Europea06:20 Erasmus y la construcción europea16:45 Por qué la política pública es cada vez más difícil20:27 El futuro de la educación21:57 ¿Está la escuela en crisis?30:39 Cómo mejorar la educación en España34:09 Cómo educar a los hijos47:01 Jacques Delors y la construcción europea53:38 El Brexit fue un error59:37 «EE. UU. es un país pobre con dinero»01:03:30 Estado del bienestar y desigualdad01:15:12 Defensa y autonomía estratégica europea01:30:14 «El dinero lo ha invadido todo»01:45:52 El futuro de la Unión Europea02:00:00 Preguntas finales——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks2. Únete al canal de WhatsApp de Arpa Editores:https://www.whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://docs.google.com/forms/d/e/1FAIpQLSfzvzXzjGDUeVLcDat7Wn4aIC0Ekf5Kj-Y8t4YSTJeiqPmaqA/viewform?usp=send_form4. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

Innovation isn't about funding, it's about how organisations are built and led. Progress comes from cutting bureaucracy, empowering mission-led teams, and asking the right questions to unlock bold breakthroughs. This week, Dave, Esmee and Rob are joined again by André Loesekrug-Pietri, Chair and Scientific Director of the Joint European Disruptive Initiative (JEDI, Europe's ARPA) to explore how Europe can turn moonshot ambitions into reality by building the right people, culture and operating models for future-shaping organisations. TLDR00:41 – Introduction01:14 – Hang out: Esmee returns and the missing API has been found!05:14 – Dig in: Staying in step with global innovation12:57 – Conversation with André Loesekrug-Pietri1:02:26 – Roland Garros tennis, and unlocking creative energy GuestAndre Loeskrug-Petri: https://www.linkedin.com/in/andrepietri/X: @eurojediwww.jedi.foundation HostsDave Chapman:  https://www.linkedin.com/in/chapmandr/Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/ ProductionMarcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/Dave Chapman:  https://www.linkedin.com/in/chapmandr/ SoundBen Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/ 'Realities Remixed' is an original podcast from Capgemini

Zarpa El Arpa - 6 de junio 2026 by Radiotelevisión de Veracruz

Pablo Melchor es el cofundador y presidente de Ayuda Efectiva, y autor del libro “Altruismo racional”. En esta conversación analiza el profundo cambio de paradigma que supone aplicar la razón, la evidencia científica y los datos a la filantropía tradicional, desafiando la idea de que la solidaridad debe ser un acto puramente emocional. Tomando como eje la asimetría del desarrollo global y la "lotería del nacimiento", reflexiona sobre cómo nuestra posición de privilegio en Occidente altera por completo nuestra percepción de la riqueza y de nuestra responsabilidad ética ante la pobreza extrema.A lo largo de la charla se debate si los marcos del mercado y el capitalismo global han fallado estrepitosamente a la hora de abordar la miseria en los entornos más vulnerables. El autor explora el coste humano de no cuantificar el impacto de las donaciones, cuestiona la falta de transparencia de las grandes ONG tradicionales y desmonta mitos arraigados como el valor real del voluntariado o la idoneidad de la empatía como brújula moral para cambiar el mundo. Asimismo, examina dilemas incómodos sobre el dinero, el concepto de herencia y la necesidad de gestionar los recursos bajo criterios de coste-efectividad para maximizar las vidas salvadas.La conversación termina con una reivindicación de la compasión racional como la tecnología más humana y eficiente para intervenir allí donde el impacto marginal de nuestro dinero es exponencialmente mayor. Frente a la inercia del buenismo estéril y la complacencia moral de Occidente, Melchor propone una hoja de ruta científica y transparente que demuestra que, hoy en día, la ayuda se puede cuantificar y que salvar vidas es, ante todo, una decisión métrica y una obligación ética.Capítulos01:30 ¿Qué es el Altruismo Eficaz?04:58 ¿Qué significa ayudar? El impacto marginal09:29 Cómo funciona Ayuda Efectiva12:36 El problema de las ONGs tradicionales24:30 Las 4 intervenciones que más vidas salvan33:02 Compasión racional y falsas soluciones37:36 Paternalismo y autonomía local56:48 Historia personal: De la empresa a la fundación1:11:04 De la realidad sobre el terreno a la psicología del donante1:25:16 Estrategia de comunicación y los límites de la empatía1:38:10 Gestión del legado, dinero y acción práctica1:42:36 Conclusiones finales  ——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks2. Únete al canal de WhatsApp de Arpa Editores:https://www.whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://docs.google.com/forms/d/e/1FAIpQLSfzvzXzjGDUeVLcDat7Wn4aIC0Ekf5Kj-Y8t4YSTJeiqPmaqA/viewform?usp=send_form4. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

Espacio dedicado a destacados solistas instrumentales nacionales e internacionales.  Con la producción de Carolina Valdés.  Jueves a partir de las 12:00 hrs. En 95.1 FM y www.radioudec.cl

Utilities, contractors, equipment suppliers, and investors have a lot of questions about federal water infrastructure funding right now. How is money moving, where is it landing, and what does project activity looks like over the next few years? Bluefield's Senior Analyst Charlie Suse joins host Reese Tisdale to walk through the federal funding landscape, from State Revolving Funds (SRF) and Infrastructure Investment and Jobs Act (IIJA) deployment to the Water Infrastructure Finance and Innovation Act (WIFIA) and American Rescue Plan Act (ARPA) wind-down. The conversation covers where capital is concentrated, why deployment gaps persist, and what the next era of federal water funding realistically looks like. Key questions include: What are the primary federal funding channels for water and wastewater utilities today? What does the current SRF landscape look like? Which segments are capturing the most funding, and which are facing the longest queues? How transformational has IIJA actually been? How do WIFIA and ARPA fit into the current market? Why does a persistent gap exist between funding commitments and shovel-ready projects? What does the next era of federal water infrastructure funding realistically look like? If you enjoy listening to The Future of Water Podcast, please tell a friend or colleague, and if you haven't already, please click to follow this podcast wherever you listen. If you'd like to be informed of water market news, trends, perspectives and analysis from Bluefield Research, subscribe to Waterline, our weekly newsletter published each Wednesday. Related Research & Analysis: The State Revolving Funds Opportunity: Tracking US$140 Billion in U.S. Water Infrastructure Demand Infrastructure Investment & Jobs Act (IIJA): Tracking the Spending, Q3 2025

The May 27, 2026, meeting of the Sacramento Area Sewer District (SacSewer) focused on the completion of a major community infrastructure project, the presentation of the upcoming fiscal year budget, and strategic financial refinancing.   Community-Wide Septic to Sewer Program The Board received a final status update on a multi-year project to convert several disadvantaged communities from septic systems to public sewer service. Completion Milestones: The district successfully connected five communities—Freeport, Linda Manor, Old Thorntown, Hood, and Franklin—totaling 219 properties, including two mobile home parks and a school. Funding Success: The $54.8 million project was primarily funded by $48.2 million in external grants from the State Water Resources Control Board, the US EPA, and ARPA funds. This allowed the district to provide the service to residents without a financial burden on existing ratepayers. Community Recognition: Representatives from the State Water Board and Congresswoman Doris Matsui's office presented awards and recognition for the program's success in protecting regional groundwater and improving public health. FY 2026-2027 Budget Workshop Staff presented the recommended budget for the upcoming fiscal year, which includes a combined operating budget of $372 million and a capital budget of $486.2 million. Labor Drivers: The budget includes a 3.3% Cost of Labor Adjustment (COLA) and a request for 21 new positions, bringing the total head count to 851. Chemical Costs: A significant driver of the 14.7% increase in services and supplies is a $10.6 million spike in chemical costs, specifically for chlorine/hypo, due to market volatility and local supplier exits. Reserves: The district maintains a healthy general reserve of 25% of operating costs. Debt Refinancing and Financial Actions The Board approved the issuance of 2026 Bonds to refinance approximately $152.3 million in existing debt. Strategic Goals: The move is designed to eliminate "sequestration risk" associated with federal Build America Bonds and is expected to generate approximately $1 million in annual debt savings. Delinquencies: The Board set a public hearing for July 22, 2026, to address $16 million in delinquent sewer charges across approximately 20,800 accounts, which will be moved to property tax roles for collection. Ordinance and Fee Updates The Board introduced a new unified "SacSewer Ordinance," merging the previously separate collection and treatment ordinances. Industrial Fee Changes: For the first time since 2007, industrial impact fees were updated, shifting from a flow-based model to an acreage-based model, which actually results in a net decrease in costs for new industrial customers. Biogas Incentives: New liquid waste hauler charges were introduced to incentivize the delivery of high-strength organic waste (such as brewery or dairy waste) to support the district's new biogas enhancement facility. Workforce and Staffing (AB 2561) The district provided a mandated update on workforce status, noting that the overall vacancy rate improved from 13.28% in 2024 to 11.93% at the end of 2025. Engineering Challenges: The Professional Engineers Group (PEA) continues to have a high vacancy rate of 22.79%, though this is down from over 30% the previous year. New Leadership Positions: The Board approved new salary schedules for three key leadership roles—Controller, Finance Manager, and Internal Auditor—to reflect the increased complexity of the department following the district's transition away from county-provided services.

Joseph Wilson was loosing the battle to Kodak when he discovered the xerography machine. Then he made it sellable. Dave Young: Welcome to the Empire Builders Podcast, teaching business owners the not so secret techniques that took famous businesses from mom and pop to major brands. Stephen Simple is a marketing consultant, story collector and storyteller. I’m Stephen’s sidekick and business partner, Dave Young. Before we get into today’s episode, a word from our sponsor, which is, well, it’s us, but we’re highlighting ads we’ve written and produced for our clients. So here’s one of those. [Handyside Ad] Dave Young: Welcome to the Empire Builders Podcast. I’m Dave Young and that’s Stephen Semple. Welcome to the Empire Builders Podcast. I’m Dave Young and there’s Steve Semple. Welcome. Oh wait, I got stuck making copies of copies. See what I did there? Stephen Semple: You’re so clever. Dave Young: You know what I did there, right? Yeah. Stephen Semple: I saw it, yeah. Dave Young: Today we’re talking about Xerox. Stephen Semple: Talking about copies of copies. Dave Young: Copies of copies of copies. Stephen Semple: Oh, and back in the day there were a lot of copies. A lot of copies. Dave Young: Oh man. I have copier stories. Yeah. Stephen Semple: I bet. I think those of us of our genre- Dave Young: Honestly, so Xerox, and we’re going to learn the story of the Xerox corporation and we’re going to… I don’t know their whole story, but I can tell you this, the photocopier or before there was something else before that. There was carbon paper. Stephen Semple: Yes, yes. Dave Young: But nobody owned a printing press. Stephen Semple: Correct, yeah. Dave Young: And so I would make the case that a photocopier was the first social media meme sharing engine. Stephen Semple: Oh, because we could photocopy our butts and share it the office. Dave Young: No, no, no, no, not your butt. I mean, I don’t know what you do in Canada. Here, I remember as a kid going to coffee, but my dad, small town, small town America, and he went to coffee twice a day with his buddies, 10 o’clock and three o’clock. They’d go down to the local cafe and they’d sit around a table and have coffee, eight or 10 of them. And somebody would always have a copy of a copy of a copy of a copy of a joke. Stephen Semple: Right. Dave Young: A cartoon, a usually off color story and they’d pass it around and then somebody would take it and make another copy of it and share it somewhere else. But you couldn’t do that if you didn’t have a copier. Stephen Semple: Well, that’s true. Dave Young: So thank you, Xerox. Stephen Semple: For making our lives richer. Dave Young: And now we can just electronically copy stuff and shoot it off as a text and a meme. Stephen Semple: One of the things you’re going to love about this story is it involves a fire extinguisher. So I’ve got your attention. Dave Young: Oh, I am all in. Stephen Semple: You’re all in. And Xerox is still pretty big. They do 7 billion in sales, but back in the early ’70s, Xerox was a monster. It’s estimated that over 10 billion copies a year were being done. Dave Young: 10 billion. Stephen Semple: That’s a lot of copies of copies of copies- Dave Young: Yeah. Once people had it, they were like, “I’m a printer.” Stephen Semple: Of copies. Yeah. Dave Young: I’m a publisher now. Stephen Semple: Yeah. In 1973, they did 3 billion in sales, which would equate to about 20 billion today. And they were close to 90% of the copier market with profit margins close to 20%. That’s just huge. It was one of the most valuable companies in the world. Dave Young: Until there started to be some competitors, Xerox became the generic word for a photocopy. Stephen Semple: Correct. Dave Young: “Give me a Xerox of this.” Stephen Semple: Yeah. So our story starts back with Joseph Wilson in Rochester, New York, which as we also know, is the home of Kodak. And Joseph was the new president of a company called Haloid, which was a Rochester based company doing photographic paper that was founded in 1906. And frankly, they were getting killed by Kodak, which at that point was 90% of the industry. And so Joseph’s trying to make headway in the photography paper business and basically is just like get nowhere. No matter what he does, he just cannot seem to create traction. Dave Young: One of his problems, Stephen? Stephen Semple: Yeah. Dave Young: Haloid. Stephen Semple: Yeah, maybe. Dave Young: That’s not a good name. Stephen Semple: Yeah, maybe. But what he decides to do is look for new opportunities. He’s actively searching through the National Patent Archive. So meanwhile, we got to think about this. It’s the mid ’40s. World War II has recently ended and the GI Bill is out there and it’s really fueling the growth of service-based industries. Banking, insurance is exploding. White collar is becoming now the thing to do. The American office is now basically the new engine of the US economy, but it’s still pretty primitive and labor-intensive. You think about going back to your whole thing, how did you copy and share information? Things were typically retyped or it was typed with a carbon paper, which meant you had one copy or a single document. Dave Young: Yeah, like a mimeograph sort of a thing maybe. Stephen Semple: Yeah, yeah. Single document could take an hour. And secretaries were manually retyping documents using carbon paper which created smudges or like as you said, the mimeograph machines, which were clunky Dave Young: Or send it, I mean, if you need more of that, you send it off to a printer. You send it off to somebody that can load it up on a printing press. Stephen Semple: Yeah. And for the people who don’t remember mimeograph machines, because I barely remember them, they stank. Dave Young: They smelled wonderful. Stephen Semple: Oh God, they were foul. They were this like, oh my God. Dave Young: The teacher would come in with a stack of stuff and hand it out and everybody would smell it. You just put it up your face and inhale. Stephen Semple: It was instead of glute. Dave Young: Weird, weird purple-y ink. I don’t even know how it worked, but yeah. Stephen Semple: So anyway, so Joseph is searching through patent archives and he comes across this invention by Chester Carlson, who’s a physicist who has got really bad arthritis and was looking for a better way to make copies. And Carlson had created, I got to read this, created an electrophotographic apparatus for dry writing. A process he turned xerography. Dave Young: Xerography, yes. Stephen Semple: There we go. Dave Young: And Haloid finally has a better name. Stephen Semple: Exactly. But the prototype was clumsy. It was large. It had been rejected by lots of people, but it caught Wilson’s eye. He could see the potential to revolutionize the office. And so it’s 1946 and he makes this big gamble. He purchases the patent for $10,000. Dave Young: Wow, okay. Stephen Semple: At that time, Haloid’s annual revenues is just a little over 100 grand. Dave Young: All right, man. Stephen Semple: So that’s a big bet. Dave Young: Huge. Stephen Semple: And the challenge was he had to turn this clumsy prototype into a viable commercial product. And there were a lot of challenges including the high heat from the fuser. It’s basically a toaster oven inside of a unit that bakes toner onto paper. Dave Young: Yeah. It puts a hydrostatic image of whatever’s on the paper on a blank piece of paper and little tiny particles of toner stick to that image and then you bake them in. Stephen Semple: Yeah. Dave Young: The little tiny microplastic things. Stephen Semple: And yes, it can catch fire. More on this later. Dave Young: Yeah. That’s why when you’re done making a bunch of copies, it all comes out warm. Stephen Semple: Yeah, exactly. So to raise money, Wilson sold some personal stock. He downsized a factory, did a bunch of things, raised about $12 million, which would be equivalent to about 140 million today and put it into development. So in 1954, after nine years of development, he has the first copier. It weighs 650 pounds. Dave Young: Sure. Stephen Semple: And it’s called the Xerox 914 because it used 9×14 paper. Dave Young: 9×14, that’s a choice. Stephen Semple: Right. Dave Young: Okay. Stephen Semple: So in addition to the $12 million that they invested, they’ve also got millions of dollars in debt. Dave Young: I’m stuck on the 9×14, Stephen. I’m thinking it’s the size of an accounting ledger, something like that. Stephen Semple: I didn’t look into why that size or… Because again, a lot of times what becomes standards change. Dave Young: Yeah. But see, that’s why you do what you do on this podcast and I do what I do. I’d have gotten stuck researching this into the 9×14 and followed that off into the woods and it would be a whole different podcast. Stephen Semple: It would be. It would be probably better. Dave Young: Oh, I don’t know about that. Anyway, I interrupted you again. Stephen Semple: So they’ve invested all this money. They’re millions in debt. They finally got a prototype and they basically say, “Okay, here’s what we got to do. We got to find a production partner to make this happen because we’re not going to produce this thing.” Dave Young: 600 pounds, yeah. Stephen Semple: Because that’s not what we do. So Wilson approaches IBM who basically at that point is a rising tech leader. Dave Young: Sure. Stephen Semple: And a lot of people don’t realize how old IBM is. I’ve got a picture of an old IBM cheese cutting machine. Dave Young: Yes, yeah. Stephen Semple: They were around forever. But anyway- Dave Young: I did a college internship at IBM. Stephen Semple: Oh, did you really? Wow. Dave Young: Where they made copiers. Yeah, I got copiers. Stephen Semple: Oh yeah. Oh, this comes back. Dave Young: Yeah, yeah. Stephen Semple: So IBM’s being run by Thomas Watson Jr. and he rejects the idea because basically it’s going to be about a $10,000 price tag and it’s going to fill a room all just for copying. He thinks this is a really, really bad idea. So Wilson doubles down, mortgages everything to make it themselves and they’re still facing these huge challenges. They meet a guy who works with equipment manufacturer AMF who’s developed this brand new sales strategy that he’s using for selling bowling alley equipment. Dave Young: Oh, is this the lease purchase? Stephen Semple: Yes, sir. Yes. So this is this brand new idea. What they decide to do is to lease the Xerox 914 for $95 a year and it would include 2,000 copies plus a nickel for each additional copy. Dave Young: Okay. So they’re selling copies, not machines. Yes, yes, yes. Stephen Semple: Right. Dave Young: Yeah. Stephen Semple: Here’s where it gets funny. It’s September 1959. The Xerox 914 makes its public debut in Manhattan. And during the demonstration, the machine bursts in the flames. Dave Young: Perfect. I’ll take three. Stephen Semple: Well, here’s the funny thing is it becomes this spectacle. It attracts onlookers and in fact the event is a resounding success. Dave Young: Yes, because the smart people will go, “Oh, they’ll fix that.” Stephen Semple: Right. Dave Young: Look, the copies came out, but they’ll fix the fire thing. Stephen Semple: Here’s what they did. Instead of re-engineering the device, remember, this is the late ’50s. The world’s a different place. Instead of re-engineering device, Wilson’s team ingeniously packages it with a fire extinguisher that they rebrand as the scorch eliminator. Dave Young: Hell yeah. Stephen Semple: Honest to God, I cannot make this up. The scorch eliminator. Oh, instead of re-engineering it, we’ll just give everybody a free fire extinguisher. Dave Young: That’s fantastic. I love that. So you could fill the paper tray with dough and pizza would come out the other end. These guys are geniuses. Stephen Semple: It’s a year later. It’s the 1960s and the machine is now available nationwide and it’s like a resounding earth-shattering success. Dave Young: Stay tuned. We’re going to wrap up this story and tell you how to apply this lesson to your business right after this. [Using Stories To Sell] Dave Young: Let’s pick up our story where we left off and trust me, you haven’t missed a thing. Stephen Semple: It’s a year later. It’s the 1960s and the machine is now available nationwide and it’s like, a resounding earth-shattering success. Production basically started at 50 per month and quickly went to 100 a day. At the end of the first year, they leased 200,000 [inaudible 00:14:32]. Dave Young: Well, this whole story, this is proof of what a good idea it was. Stephen Semple: Oh, absolutely. Dave Young: People don’t care if it catches fire as long as I get some copies out of it. Stephen Semple: Yeah. And the copier room becomes a new social hub. It becomes the way we share jokes. Dave Young: You want to make sure it has some overhead sprinklers. Stephen Semple: Well, you’ve got the scorch eliminator. You’re good. The company gets officially renamed Xerox Corporation and really it launches the information revolution. The stock quadruples, revenue soared at 250 million. Now, remember IBM? Dave Young: Oh yeah, they come around. Stephen Semple: The guys who rejected the idea. So the number of copies being made annually in the United States surges from 20 million to over 9 billion with Xerox basically dominating. And IBM, remember, took a pass, but they decided to enter the business in the early 1970s. They create their own copier. Now- Dave Young: They figured out that they were the biggest customer of Xerox. Stephen Semple: Yeah, essentially. Yeah. Dave Young: Yeah. Stephen Semple: Now, Joseph had a choice at this point. He knew they were leveraging his technology, but he also knew that it would be hard for him to win on legal grounds alone. So what he decided that he needed to do was to out innovate them. Dave Young: Okay. Stephen Semple: And so what Joseph Wilson envisioned was an office of the future because he saw computers coming. Remember, this guy was a visionary. He saw computers coming. Dave Young: Oh, yeah. I love this guy. Stephen Semple: But the problem, computers were large, difficult to use, but he was like, “I saw what happened with the photocopier, it went from being massive to small. Computers, same thing’s going to happen.” Dave Young: Yeah, yeah. Stephen Semple: So he decided to invest the equivalent of $20 million to establish PARC, the Palo Alto Research Center. Now, he hired a top computer scientist from ARPA, Robert Taylor, and gave him a clear mandate, “Pull together the brightest folks and create the next technological revolution.” The goal was for it to be this visionary think tank to leapfrog everybody. Here’s what they created. Gary Bernier and I did another podcast on this, which talked about this failure of Xerox. And there’s something I didn’t realize until doing this research, which kind of filled in a blank. So I actually recommend people go back and listen to that podcast. But here’s what they created, networking, the mouse, and the graphical user interface. If Xerox had developed that today, Xerox would be the giant of the industry. Could you imagine? Dave Young: Did they also figure out printing to like laser printing? Stephen Semple: I’m not sure whether it was laser printing- Dave Young: I’m sure who- Stephen Semple: But they did invent the whole idea of what you see is what you get, like that whole idea that the screen… But I’m not sure whether it was laser or not. Dave Young: Basically, when I was at IBM, that’s what they were making, were photocopiers that were also laser printers. You could go photocopy something by standing at the machine or you could send a document to it and have it printed. Stephen Semple: And so here’s the interesting thing because I’d always wondered why did these things not get to market? And here’s what actually happened. Before these things were finally created in terms of prototype level, Wilson died and the executives who were basically under him took over and they didn’t have the vision and they saw the paperless office as cannibalizing their business. Kind of like Kodak. Remember Kodak developed all the stuff for digital cameras and went, “Oh, well, we can’t do this because it’s going to cannibalize our business.” Dave Young: Yeah. WYSIWYG, mouse. That’s not the business. Stephen Semple: Right. Well, and remember we did an episode a little while ago where we were talking about the iPhone and the brilliance of Steve Jobs. He was willing to cannibalize their own business to make that happen. When you’re unwilling to cannibalize your own business, you got a problem. This is the same thing that killed Kodak. It’s the thing Jobs overcame to create the iPhone. So speaking about Jobs, the idea for the Mac came from a visit at PARC. In 1979, Jobs negotiated a tour of PARC in exchange for allowing Xerox to invest in Apple’s pre-IPO stock. And basically Jobs saw all this stuff, saw the mouse, saw the graphical user interface and went, “Holy crap, this is the future. This is the future.” So again, when Gary and I did this episode talking about Xerox and the failure of Xerox and the success of, har, Palo Alto, I never realized the timing of the death of the founder. Dave Young: Yeah. Stephen Semple: And it explains so much in terms of the execs not getting the idea. He would’ve. Joseph would’ve. Dave Young: Oh, I think so. Yeah, for sure. Stephen Semple: He would’ve been all over it. And Xerox would be a different company today. Dave Young: Yeah. Pretty amazing. Stephen Semple: But the things that I really loved on this is, again, Joseph was looking, he saw this world trend. He was in the photo paper business and he saw this whole idea of a copier, but also greater than that, it wasn’t just the idea of the copier. He saw what was the importance of the office and what was going on in office space. And the other part that I loved, and then proactively went looking for innovative ideas. And the part that I really love the most is they didn’t let the fire stop them. Dave Young: I do. Yeah, that’s so great. I don’t know. Yeah, some people say that’s a negative, but here’s a fire extinguisher. Stephen Semple: Right. Now granted, it was the late 50s, early 60s, different era. Dave Young: Here’s the thing, Stephen, offices can be kind of boring. And if you can introduce the prospect that there’s going to be a fire down in the copy room every now and then, there’s something to talk about while you’re standing around the water cooler. So when I worked for- Stephen Semple: It’s a whole different thing of lighting a fire under people’s ass. Dave Young: Oh yeah, yeah. I keep an emergency bag of marshmallows in my desk drawer in the hope that the copier catches fire. I did my college internship at IBM. It was a paid internship. So I can legitimately say I worked for IBM back in the day. It was back in the day when they actually manufactured stuff. IBM made machines. Now they just… I don’t even know what they do. They consult? Do they- Stephen Semple: There’s still a lot of IBM technology in the backgrounds, like with servers and things along… How much they manufacture versus just license, that I don’t know. Dave Young: So they’re a software and consulting company and felt all of that. But in 1984 they were still manufacturing, I worked for their Boulder, Colorado plant and it was 5,000 people working there. Stephen Semple: Amazing. Dave Young: And they made floppy drives and printers and printer/copiers. So you could buy a photocopier/printer the size of a large deep freeze and they’d install it. And I think they probably same thing, probably same business model. You’d pay by the copy, you’d rent the machine. One of the coolest things was that they had a laboratory at that facility. And in the laboratory, they had a copier lab where they had Xerox and Canon and all the other competitors, they had machines installed. They would call Xerox and say, “Hey, we need a machine, bring it here, install it in the lab and we want the usual maintenance agreement. So you got to send a Xerox guy to come maintain this thing.” And they would run that machine all day long making test patterns. They would print test patterns all day long and then evaluate them, put them under the microscope, see where that machine was performing and how it performed against theirs. I mean, it was kind of a cool lab. Who does that? Stephen Semple: So the other thing I just want to add on Xerox before we finish off, because I forgot to mention this as one of the lessons and this is actually probably the most important lesson. And that is, they looked at the guy selling bowling alley equipment and did the leasing. That was brand new, but they did an interesting twist to it that I think can be overlooked in terms of the real power of what they did. Because sure, leasing made it easier to purchase, but there’s two additional things that they did that made it easy to purchase 2,000 copies included. Which meant immediately if you’re going, “I’m leasing this for 100 dollars a year, 2,000 copies. Oh, that means my copy is so many cents a copy.” Dave Young: And if I never make another copy, yeah. Stephen Semple: Right away I’m saving money. So it allows for the financial justification becomes really easy. But here’s the other thing that becomes wild is, when I put the machine in, I’m not saying to people, “Hey, be careful how much you use this.” My goal is I want 2,000 copies to happen. Once I create the habit of people creating copies, it’s now embedded in the business. Dave Young: And then you have bean counters that tell you… Yeah. Stephen Semple: Well, could you imagine how different it would be is if it was less money, $50.05 a copy, you’d be telling everybody, “Now be careful how often you copy.” Dave Young: Yeah, but even then they were. Stephen Semple: Right, no, but the point is it allowed the habit. It allowed the habit to happen. It was just because you wanted to use up the 2,000, 2,000 copies. So anyway, I just think there was brilliant, especially for brand new technology, a brilliance in terms of how they structured that lease. Dave Young: They found an interesting business model to copy- Stephen Semple: They did. Dave Young: In a completely unrelated field. Stephen Semple: They did. Dave Young: And that’s the benefit of getting outside of your category to look for innovation. Stephen Semple: And then put a twist on it that eliminated friction of using that equipment because the first 2,000 copies were free. Anyway, I just thought it was brilliant. I just wanted to point that out. Dave Young: Yeah. I love, what was his name again, Wells? Stephen Semple: Joseph Wilson. Dave Young: Wilson. Well, I know there’s a W in there. Joseph Wilson. Stephen Semple: Yeah, Joseph Wilson. Yeah. Dave Young: All right. It was a good he didn’t name it Wilsonography. But I love it. I love the Xerox story. Thank you, Stephen. Stephen Semple: All right. Awesome. Thanks, David. Dave Young: Thanks for listening to the podcast. Please share us, subscribe on your favorite podcast app and leave us a big, fat, juicy five star rating and review at Apple Podcasts. And if you’d like to schedule your own 90 minute empire building session, you can do it at empirebuildingprogram.com.

✨ En este episodio de Hadas y Nalgadas nos metemos de lleno al caos emocional, mágico y sexy de los capítulos 51 al 54 de A Court of Silver Flames de Sarah J. Maas. Hablamos de la evolución brutal de Nesta Archeron, el nacimiento oficial de las nuvas Valquirias y, OBVIAMENTE, del momento en que el Arpa del Tesoro del Miedo despierta y cambia todo el juego. Analizamos uno de los bloques más intensos, místicos y cinematográficos de toda la saga ACOTAR. Si amas romantasy, fantasy books, Sarah J Maas theories, Night Court drama, Nessian y las teorías conspirativas del Maasverse… este episodio ES para ti. ✨

In this episode, I am  joined by Sarah Stock, Professor and Consultant in Maternal and Fetal Health, and one of the leading global voices in stillbirth and preterm birth research. Sarah's work spans laboratory science, clinical trials, and large-scale international data-driven research focused on improving outcomes for mothers and babies worldwide.Sarah earned her MD from Manchester University Medical School and her PhD in Reproductive Biology from the University of Edinburgh, later completing specialist and subspecialist Maternal and Fetal Medicine training across Edinburgh, Glasgow, London, and Australia.Sarah currently serves as Program Director at Wellcome Leap, where she leads the $50M In Utero program  an ambitious initiative aiming to reduce stillbirth rates by 50% by building scalable technologies that can measure, monitor, and predict fetal development in real time.Stillbirth affects more than 2 million families every year  roughly one baby every 16 seconds  yet it remains one of the most overlooked global health challenges. In this conversation, we explore why pregnancy care has remained largely unchanged for decades, how emerging technologies could transform maternal and fetal care, and where founders and innovators can create meaningful impact.In this episode, we discuss:• Sarah's journey into maternal–fetal medicine and stillbirth research• Why stillbirth continues to be a neglected global health crisis• The vision behind Wellcome Leap's In Utero program• How the ARPA-style innovation model differs from traditional research funding• Technologies needed to measure placental, maternal, and fetal health at scale• Wearables, AI, biomarkers, and the future of pregnancy monitoring• Challenges founders face in women's health and maternal care• How Wellcome Leap supports breakthrough innovation beyond funding alone• The biggest market opportunities in women's health over the next 3–5 years• What success looks like for the future of maternal healthcare• How founders and researchers can engage with the ecosystemIf you're a founder, investor, researcher, healthcare leader, or someone passionate about women's health innovation, this episode offers an inside look at one of the biggest opportunities to reshape the future of healthcare.This episode is brought to you in partnership with FemTech India a global women's health ecosystem building and scaling startups to close the gender gap in emerging markets like India.Disclaimer: The content shared in this episode is intended for general awareness and discussion purposes only. It should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal health decisions. ©️TechThrive Ventures. All rights reserved.Newsletter - https://techthrivenewsletter.beehiiv.com/Sarah Stock - https://www.linkedin.com/in/sarah-stock-92605449/Wellcome Leap $50M Utero program - https://wellcomeleap.org/inutero/ Connect with us Instagram: ⁠⁠https://www.instagram.com/ctrl.alt.thrive.podcast/⁠⁠ Youtube :⁠⁠⁠ ⁠https://www.youtube.com/@Ctrlaltthrive/videosConnect with Navneet Linkedin : ⁠⁠https://www.linkedin.com/in/navneet-kaur-80109b227/⁠⁠Instagram : ⁠⁠https://www.instagram.com/nav_neeetkaur/⁠

Zarpa el Arpa - 23 de mayo 2026 by Radiotelevisión de Veracruz

Enric Juliana es periodista y escritor, y Esteban Hernández es analista político y ensayista. En esta conversación analizan las profundas transformaciones geopolíticas actuales a raíz de la pérdida de la hegemonía de los Estados Unidos y la irrupción de China como la gran potencia tecnológica del futuro. Tomando este giro histórico como eje, reflexionan sobre cómo el control de las cadenas de suministro y las nuevas rutas comerciales en el Ártico están redibujando por completo el mapa mundial.A lo largo de la charla se debate si es posible gestionar la vertiginosa competición por la inteligencia artificial y las materias primas críticas desde los marcos de la democracia liberal. Los autores exploran el retorno del poder político fuerte y el auge de un nuevo autoritarismo a escala global, al tiempo que examinan el desgaste de las instituciones, la crisis de los medios de comunicación y el desencanto de una sociedad civil que anhela recuperar la ilusión colectiva.La conversación termina con una mirada al impacto de la guerra de Ucrania como un acelerador geopolítico que ha terminado por consolidar el eje euroasiático entre Rusia y China. Frente al riesgo de un vacío de poder y una creciente incertidumbre, Juliana y Hernández reivindican la necesidad de recurrir a la historia, más que a los datos y los porcentajes, para intentar comprender qué nos es lícito esperar del siglo XXI.CapítulosCapítulos00:00 Introducción01:50 El nuevo orden mundial06:01 La guerra por los recursos10:56 El auge del autoritarismo17:10 La crisis del bienestar22:01 Tecnología y límites físicos30:24 El descrédito de la política35:52 Polarización y control social39:30 El valor de la historia54:35 Occidente vs. Modelo chino01:11:58 El proyecto de Trump01:15:27 El factor desigualdad01:24:15 Eje Rusia-China y Ucrania01:35:23 El futuro de Europa01:51:58 Cierre——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks2. Únete al canal de WhatsApp de Arpa Editores:https://www.whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://docs.google.com/forms/d/e/1FAIpQLSfzvzXzjGDUeVLcDat7Wn4aIC0Ekf5Kj-Y8t4YSTJeiqPmaqA/viewform?usp=send_form4. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

After spending time in the Obama White House, Kumar Garg came away with a toolset of skills to help drive change, spotlight good ideas and scale them. Now he's applying those ideas to philanthropy. As the co-founders of Renaissance Philanthropy, Kumar and Tom Kalil have built an organization around a deceptively simple idea: What if philanthropy could help scientists, technologists, and innovators think bigger — and then actually fund the work at the scale required?Kumar and Claudia dive into:Renaissance Philanthropy's approach: time bound and thesis driven fundingHow Kumar would spend $500 million on health right nowHow public health and academics could think biggerKumar's intriguing ‘open notebook' idea:“It's very valuable to me if a researcher has the equivalent of an open notebook. These are all the ideas… Here's my active research projects. Here's all the interesting sort of experiments I've done… you can imagine then sending an agent out and read[ing] people's open notebook.. it would be a way to discover people's work.”Relevant LinksLearn more about Renaissance PhilanthropyGet info on the Big If True Science Accelerator (BITS)See a photo of Kumar's White House white board on TwitterAbout Our GuestsKumar Garg is the President at Renaissance Philanthropy.Kumar has helped to shape the science and tech landscape for almost two decades. Working with Eric Schmidt, he helped design and launch moonshot initiatives in education, provided early support to game-changing ideas and pioneers, and built ongoing multi-donor and multi-sector collaboratives.Prior to that, he helped set budget and policy priorities for the Obama Administration as part of the White House Office of Science and Technology Policy, and drove progress on topics ranging from education and workforce issues, biotechnology, entrepreneurship, space, advanced manufacturing, broadband, nanotechnology, behavioral sciences, digital media, incentive prizes, and broader innovation policy.In particular, he led the Obama Administration's efforts to bolster science, technology, engineering and math (STEM) education, including development of major budget and policy initiatives in the State of the Union to train 100,000 excellent STEM teachers and bring computer science to all K-12 students, development of the Educate to Innovate campaign with over $1 billion in in-kind and philanthropic investment, and creation of iconic events such as the White House Science Fair.Prior to his time in government, Kumar worked on behalf of parents and children seeking educational reform as an education lawyer and advocate. Kumar received a B.A. from Dartmouth College and a law degree from Yale Law School.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!

Eudald Carbonell es uno de los arqueólogos más importantes del mundo. Es un honor tenerlo en nuestro programa. Fue premio Príncipe de Asturias y director de las excavaciones de Atapuerca. Ahora, junto a Igor Parra, acaba de publicar una obra sobre la historia de la evolución humana titulada Los pilares de la evolución humana (Arpa). Con él hablamos de vida en otros mundo, de los neanderthales, de la Inteligencia Artificial...

Zarpa el Arpa - 16 de mayo 2026 by Radiotelevisión de Veracruz

Alberto Garzón es economista, exministro de Consumo y excoordinador de Izquierda Unida. En esta charla reflexiona sobre cómo la búsqueda de energía ha marcado la historia humana y los conflictos geopolíticos actuales. Usando su libro «La guerra por la energía» como marco, analiza la crisis civilizatoria y el choque entre el crecimiento infinito y los límites físicos del planeta. Se debate la «anomalía» de los combustibles fósiles y el concepto de «esclavos energéticos»: las máquinas que hoy realizan el trabajo que antes hacían personas. Garzón explora las posibles salidas al colapso, desde la planificación democrática hasta el riesgo de derivas autoritarias, cuestionando un sistema que opera como una fuerza ciega de expansión constante. La conversación termina con una mirada íntima a su paso por la política institucional y el Consejo de Ministros. Relata el desgaste de la exposición pública y las dinámicas internas de poder, reivindicando la necesidad de humanizar la figura del político y proteger los espacios de vida privada frente a la hostilidad y el ruido del escenario mediático actual.——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks 2. Únete al canal de WhatsApp de Arpa Editores:https://whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v 3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://forms.gle/DJHyLwVgLk9weY9H84. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬ Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

Welcome to the Monday Night Talk podcast for April 6, 2026. The guest and topic for this segment includes a Plymouth County Update with County Commissioner Chairwoman Sandra Wright, who breaks down the county budget, the final phase of ARPA fund distribution, her key initiatives, and her campaign for a fifth term this fall. New Bedford City Councilor Shawn Oliver joins the show to discuss being tapped as the Lieutenant Governor running mate alongside Brian Shortsleeve—and what their ticket is bringing to voters across Massachusetts. Whitman Select Board member Justin Evans talks about the town's serious FY2027 budget challenges ahead of Town Meeting—including difficult conversations about potential cuts and the future of the public library. Rob Coakley stops by to preview and predict the biggest matchups for WrestleMania 42, coming to Allegiant Stadium in Las Vegas. Monday Night Talk is proudly sponsored by Tiny & Sons Glass and Alcoholics Anonymous. Do you have a topic for a future show or info on an upcoming community event? Email us at mondaynighttalk@gmail.com If you're a fan of the show and enjoy our segments, you can either download your favorite segment from this site or subscribe to our podcasts through iTunes & Spotify today!  Monday Night Talk with Kevin Tocci - Copyright © 2026.

Zarpa el Arpa - 9 de mayo 2026 by Radiotelevisión de Veracruz

Marcos Vázquez es ingeniero informático y creador de Fitness Revolucionario y Pablo Vázquez es ingeniero informático y autor de Tsunami. En esta conversación explican qué es realmente la inteligencia artificial, cómo funciona físicamente —chips, centros de datos, energía— y por qué de algo tan aparentemente sencillo como predecir la siguiente palabra emerge algo que se parece tanto a la inteligencia.A lo largo de la charla se habla de las alucinaciones y los errores de la IA, de en qué se parecen y en qué se diferencian de los errores humanos, y de los riesgos reales de una tecnología que avanza más rápido que nuestra capacidad de regularla. También de si una IA con intereses propios podría llegar a ser una amenaza, y de cómo adaptarse sin caer ni en el catastrofismo ni en la ingenuidad.La conversación termina con el mercado laboral y la educación: qué trabajos están en riesgo, cuáles no, y qué tendría que cambiar en la escuela para preparar a las próximas generaciones para un mundo que todavía no sabemos muy bien cómo va a ser.——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks 2. Únete al canal de WhatsApp de Arpa Editores:https://whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v 3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://forms.gle/DJHyLwVgLk9weY9H84. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬ Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

In questa puntata del podcast, Pasquale Viscanti e Giacinto Fiore riflettono sul ruolo dell'intelligenza artificiale nella sostenibilità ambientale, partendo da un caso concreto: l'accordo siglato da Meta per alimentare i propri data center con energia solare. Nel corso della conversazione commentano anche quanto accaduto nel Maine, dove la governatrice Janet Mills ha posto il veto a una legge che avrebbe introdotto una moratoria sui nuovi grandi data center fino al 2027, aprendo un dibattito importante sull'impatto energetico e ambientale di queste infrastrutture e sul loro futuro.Ospite della puntata è Donato Ramunno, Direttore Generale di ARPA Basilicata, che porta una visione concreta e istituzionale sul rapporto tra tecnologia e ambiente. Il confronto arricchisce il dialogo con spunti pratici e una riflessione chiara su come pubblico e privato possano collaborare per un futuro più sostenibile.Incontra tutti i protagonisti dell'AI alla AI WEEK 2026: Arsenalia, PwC, AltermAInd, NTT Data, Reply e tanti altri. Scoprili tutti su https://www.aiweek.it Pasquale Viscanti e Giacinto Fiore ti guideranno alla scoperta di quello che sta accadendo grazie o a causa dell'Intelligenza Artificiale, spiegandola semplice.Puoi iscriverti anche alla newsletter su: https://www.iaspiegatasemplice.it

Zarpa el Arpa - 2 de mayo 2026 by Radiotelevisión de Veracruz

Putnam County races to spend federal funding An effort by Putnam legislators to preserve federal funds for a nonprofit whose mental-health crisis center has been rejected by Brewster and Carmel now centers on buying a home it rents in Philipstown for people needing respite. Nancy Montgomery, who represents Philipstown and part of Putnam Valley on the Legislature, and its chair, Dan Birmingham, unveiled on Monday (April 27) a proposal to allow People USA to keep $2.1 million in American Rescue Plan Act funds to buy 111 Philipse Brook Road, which is on the market for $1.3 million. After debating the idea for more than an hour, the Budget and Finance Committee, which includes every legislator, postponed a vote on whether to terminate a contract with People USA to open a 24-hour, drop-in "stabilization" center for people experiencing a mental-health or substance-abuse crisis. People USA initially planned to lease space above a childcare center in Brewster, but that sparked outrage from residents and led the Town of Southeast to impose a moratorium on permits for medical and mental-health clinics. The nonprofit then tried to open a stabilization center in an office building in Carmel. That provoked similar opposition, and the town's Planning Board rejected the application. The two rejections have made it impossible for People USA to spend the money by June 1, which is a provision of the contract, according to Bill Carlin, the county finance commissioner. Because of approaching federal deadlines, he asked the Legislature to divert the funds to paving projects. The county received $19 million in pandemic relief funding; under ARPA rules, money for paving projects must be spent by September and for anything else by Dec. 31. To replace People USA's funding, County Executive Kevin Byrne wants to take $2.1 million from Putnam's savings for mental-health initiatives. But Birmingham said he has "an uncomfortableness with trading human services dollars for blacktop." And Montgomery said that she has been told by the U.S. Treasury Department that ARPA contracts can be amended. Revising the People USA contract to specify "stabilization services" instead of a center is "much less risky," she said, and would preserve an existing service by allowing the nonprofit to buy the Philipstown home. "Once this money disappears from ARPA for public health for People USA, we're not going to get that money back for stabilization services," she said. The Philipstown property is part of People USA's network of Rose Houses, places of respite "operated by peers who have their own personal lived experiences" with a mental-health crisis. People can stay up to seven days and are free to come and go for jobs and other reasons. Rebecca Valk, a lawyer for People USA, said buying the house would "give us a stronger foot" in Putnam. "We have not found a community that does not seem to be scared of the individuals that we serve," she said. People USA said it has received state approval for renovation plans for Philipstown Brook Road. But Valk said that because the organization "would be flowing with the services that are already there" and not building a center like the ones proposed for Brewster and Carmel, no approvals would be needed from Philipstown. Supervisor John Van Tassel had a different view. He told legislators that he only found out about the proposal less than two hours before the 5:45 p.m. meeting and "was a little disappointed that I wasn't included in any of the communications." Under the town's zoning code, only single-family homes are permitted in that area, he said. "Whatever is operating there currently, I don't know if it's there illegally, but any adaptation to that building would require site plan approval," he said.

Pasquale Viscanti e Giacinto Fiore intervistano Valerio Summo, responsabile della Transizione Digitale, Open Data e Intelligenza Artificiale di ARPA Puglia, per capire come una Pubblica Amministrazione possa evolvere in una vera AI-Driven Company. La conversazione parte da casi concreti legati all'ambiente e al monitoraggio del territorio, mostrando come l'uso dei dati e dell'AI possa migliorare l'efficacia delle decisioni e dei processi.Nel corso della puntata emergono le principali sfide organizzative e culturali che la PA deve affrontare, insieme alle opportunità offerte da un approccio data-driven. Tra Open Data, innovazione e applicazioni reali, viene delineato un percorso chiaro e replicabile per portare l'Intelligenza Artificiale al centro delle strategie pubbliche.Incontra tutti i protagonisti dell'AI alla AI WEEK 2026: Arsenalia, PwC, AltermAInd, NTT Data, Reply e tanti altri. Scoprili tutti su https://www.aiweek.it Pasquale Viscanti e Giacinto Fiore ti guideranno alla scoperta di quello che sta accadendo grazie o a causa dell'Intelligenza Artificiale, spiegandola semplice.Puoi iscriverti anche alla newsletter su: https://www.iaspiegatasemplice.it

Zarpa el Arpa - 25 de abril 2026 by Radiotelevisión de Veracruz

Lola López Mondéjar es psicoanalista y autora de "Invulnerables e invertebrados" y "Sin relato". En esta conversación explica qué es el psicoanálisis, para qué sirve y qué dice de nosotros el tipo de malestares que produce nuestra época.También se habla de Freud y de la herencia del psicoanálisis, de cómo la técnica y el capitalismo han moldeado nuestra forma de vivir y relacionarnos, y de si es posible imaginar modelos que devuelvan la dignidad humana al centro.La conversación recorre algunos de los grandes temas de su trabajo: la ansiedad, la depresión y la hiperadaptación como patologías del tiempo presente; la dificultad para construir una identidad propia en una cultura que prima la acción sobre la reflexión; o el papel que juegan la sexualidad, el género o el hecho de ser padre en la formación del sujeto contemporáneo.——¿Quieres apoyar Arpa Talks?1. Patrocina Arpa Talks y recibe libros de Arpa cada mes. https://arpaeditores.com/products/patrocinio-arpa-talks 2. Únete al canal de WhatsApp de Arpa Editores:https://whatsapp.com/channel/0029Vb7dsfcFXUuRmK8aoM0v 3. Responde nuestra encuesta. Te llevará un minuto y es anónima:https://forms.gle/DJHyLwVgLk9weY9H84. ¡Compra libros de Arpa! http://www.arpaeditores.com——YouTube: ‪@ArpaTalks‬ Spotify: https://bitly.cx/G6aCDApple Podcast: https://bitly.cx/gLW2INewsletter: https://arpaeditores.com/pages/newsletterTwitter: https://x.com/arpaeditoresMail: talks@arpaeditores.com——Música original de Alfo G. Aguado x Udio

A 10 out of 10. That’s how interesting, or maybe it was how "important," Mac Kiel thought the April monthly city council meeting was. She stopped in studio to help recap the meeting, which included things like the city police being a couple hundred thousand dollars over budget, while other city departments were under budget and how the city council learned of this over the past few weeks. Another thing the council apparently learned over the past few weeks is that the city had around $300,000 in ARPA interest funding with no official plan to use it. That led to one council member proposing using $90,000 to open the North Side Community Pool this summer last minute. So, we discussed that revelation and the dilemmas to having the pool open for the season — while there are also plans to build a new indoor pool facility at that site potentially. We also discussed — to a degree — using $400,000 in TID money on the Civic Center Park District. It’s a thing we discussed before it made its round on council and how the TID money does or does not have to be used before it expires. Lastly, we talked about the La Crosse School Board’s decision earlier this week to keep the old name for a new elementary school, while renaming an old school. We also discussed briefly the names that were not picked. Kiel is a former La Crosse City Council member, who is an advocate for providing the public with what is happening with city government. She also serves on some city boards and works with the unsheltered population.See omnystudio.com/listener for privacy information.

In questa puntata del podcast Intelligenza Artificiale Spiegata Semplice, Pasquale Viscanti e Giacinto Fiore inaugurano il nuovo spin-off “AI PER L'AMBIENTE”, realizzato in collaborazione con ARPA Puglia.Protagonista dell'episodio è l'Avv. Vito Bruno, Direttore Generale di Arpa Puglia, che racconta come un ente pubblico strategico possa sfruttare i dati e l'Intelligenza Artificiale per prevenire rischi e tutelare ecosistemi fondamentali come mare, aria e ambiente urbano.Nel corso dell'intervista, viene inoltre approfondita la visione e la strategia alla base del "Progetto DARE" finanziato PNC/POC, l'iniziativa con cui ARPA Puglia insieme ad altri partner sta iniziando a integrare concretamente l'AI nei propri processi, aprendo nuove prospettive per la protezione ambientale e la gestione intelligente del territorio.Incontra tutti i protagonisti dell'AI alla AI WEEK 2026: Arsenalia, PwC, AlterMind, NTT Data, Reply e tanti altri. Scoprili tutti su https://www.aiweek.it Pasquale Viscanti e Giacinto Fiore ti guideranno alla scoperta di quello che sta accadendo grazie o a causa dell'Intelligenza Artificiale, spiegandola semplice.Puoi iscriverti anche alla newsletter su: https://www.iaspiegatasemplice.it

"The men are going to tell you the ugly truth… so he can see what the truth is and then make an educated decision and be put into action rather than just shit talk." A lot of men go through life trying to figure things out on their own—and it usually doesn't work that well. A men's group gives you something most men don't have: other men who will actually tell you the truth. Not to tear you down, but to help you see where you're off and what needs to change. It's not about sitting around venting or getting comfort. It's about being challenged, getting clear on your standards, and actually following through. When you've got other men in your corner who won't let you slide, things start to shift fast. Rob Arpa, Larry Cooper, and Jeff Banks all hit this from different angles, but they land in the same place. You need other men. Larry talks about how much you can learn just by being around men with more experience. Jeff brings up that feeling of having an "invisible army" behind you—knowing you're not doing life solo anymore. And Arpa keeps it grounded in standards and behavior. It's not about what you say you want—it's about what you actually do. That's where the group comes in. They close the gap. All three are members of the Sovereign Circle, bringing years of experience in business, leadership, and personal development. Their work is focused on helping men raise their standards, take ownership of their lives, and show up better—in their work, their relationships, and for themselves. You're invited to come to a Sovereign Circle meeting to experience it for yourself. To learn more, go to https://www.sovereignman.ca/. While you're there, check out the Battle Ready program and check out the store for Sovereign Man t-shirts, hats, and books.

In an era where technological progress reshapes power, security, and prosperity at unprecedented speed, societies face a defining choice: adapt incrementally or reinvent boldly. How can breakthrough and disruptive technologies enable strategic leapfrogging, transforming long‑term ambition into real‑world impact amid a rapidly shifting global landscape.This week, Dave, Esmee, and Rob are joined by Andre Loesekrug-Pietri, Chair and the Scientific Director of the Joint European Disruptive Initiative (JEDI, the European ARPA), to explore the ambition behind and what it would take for Europe to stop reacting to technological change and start shaping it. TLDR00:30 – Guest introduction and overview of this week's conversation01:35 – Team Dig in: Is Europe falling behind on competitiveness?13:52 – Conversation with Andre Loesekrug-Pietri1:00:19 – Traveling to Japan with the French president GuestAndre Loeskrug-Petri: https://www.linkedin.com/in/andrepietri/X: @eurojediwww.jedi.foundationHostsDave Chapman:  https://www.linkedin.com/in/chapmandr/Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/ ProductionMarcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/Dave Chapman:  https://www.linkedin.com/in/chapmandr/ SoundBen Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/ 'Realities Remixed' is an original podcast from Capgemini

Send us Fan MailThe American Rescue Plan's State and Local Fiscal Recovery Funds became law five years ago. It's a program that provided funding directly to communities of all sizes across the country. At the time, pandemic-driven revenue shortfalls were threatening widespread municipal layoffs, service cuts, and there were serious concerns that we were headed into another 2008-style recession. Guest host, Irma Esparza Diggs, discusses the historic impacts of ARPA with Mike Fina, Oklahoma Municipal League Director; Dan Gilmartin, Michigan Municipal League Director; and Todd Glover, Municipal Association of South Carolina Director.For more information, visit us at nlc.org.

Lead pipes aren't just a water infrastructure problem—they're connected to poverty, violence, and lost opportunity. Milwaukee's mayor explains why removing them matters to public safety and economic mobility. Host Stephen Goldsmith speaks with Milwaukee Mayor Cavalier Johnson about how his city is accelerating lead pipe removal, creating family-supporting jobs, and why environmental justice is central to breaking cycles of poverty and incarceration. In this episode, you'll learn:    Why lead exposure affects public safety, not just health    How lead removal becomes an economic development opportunity for neighborhoods    Why early interventions in kids' lives prevent long-term harm    How Milwaukee prioritizes removal in the most under-resourced neighborhoods    What federal funding will enable Milwaukee to remove 5,000 lead pipes in a single year Listener Survey: bit.ly/datasmartpod Music credit: Summer-Man by Ketsa About Data-Smart City Solutions Data-Smart City Solutions, housed at the Bloomberg Center for Cities at Harvard University, is working to catalyze the adoption of data projects on the local government level by serving as a central resource for cities interested in this emerging field. We highlight best practices, top innovators, and promising case studies while also connecting leading industry, academic, and government officials. Our research focus is the intersection of government and data, ranging from open data and predictive analytics to civic engagement technology. We seek to promote the combination of integrated, cross-agency data with community data to better discover and preemptively address civic problems. To learn more visit us online and follow us on LinkedIn.

Analysts Don Kellogg and Roger Entner evaluate AT&T's new OneConnect plan, examining its impact on both consumer value and the competitive landscape, as well as new price increases for existing subscribers.00:00 Episode intro 00:26 New OneConnect plan overview 04:01 ARPU is waning as a metric 04:30 AT&T's strategy with the plan 05:23 Price increases on existing customers 06:21 Will price hikes backfire? 07:54 The company remains focused on the long term 08:33 Episode wrap-upTags: telecom, telecommunications, wireless, prepaid, postpaid, cellular phone, Don Kellogg, Roger Entner, AT&T, OneConnect, convergence, fiber, cable, FWA, ARPU, ARPA, T-Mobile, bundling, price increases, churn, revenue, EBITDA

"Entitlement always leads you down a suck hole of hate, anger, and jealousy" Most men don't realize how much their mindset shapes the outcomes they experience. An entitled mindset quietly assumes life owes you something—opportunities, success, rewards—without the need to earn them. A gratitude mindset flips that entirely. It recognizes that nothing is guaranteed, and everything worthwhile comes through value, effort, and contribution. The shift is subtle but powerful: one leads to frustration, comparison, and stagnation, while the other builds momentum, resilience, and fulfillment. At its core, gratitude creates action, while entitlement breeds inaction. Rob Arpa breaks this down in practical terms, especially in work and relationships. He points out that entitlement often shows up as expecting more without delivering more, while gratitude shows up as over-delivering and appreciating the opportunity to create value. Arpa emphasizes that men who succeed consistently aren't waiting to be rewarded—they're actively earning trust, building relationships, and making "deposits" through effort and consistency. That same principle applies across life: friendships, business, and partnerships all thrive when approached with a mindset of giving rather than taking. Learn more & connect: Rob is the owner/operator of Green FX Landscaping, located in Etobicoke, Ontario. He's a veteran in the men's movement and a member of the Sovereign Man Iron Council. Learn more & connect: https://www.greenfxlandscaping.ca/ You're invited to come to a Sovereign Circle meeting to experience it for yourself. To learn more, go to https://www.sovereignman.ca/. While you're there, check out the Battle Ready program and check out the store for Sovereign Man t-shirts, hats, and books.

Aplicadas ya más de 30 millones de vacunas contra sarampión Inicia veda del camarón en el Alto GolfoA principios del siglo XVII el arpa fue introducida en la cultura yaquiMás información en nuestro podcast

Fake Claude Code Installs, Arpa Phishing, Zombie ZIP Malware Evasion, and Iran/Israel Cyber Retaliation This episode covers four major security stories: the "InstaFix" campaign using Google sponsored ads and cloned Claude Code install pages to trick developers into pasting terminal commands that deploy the TeraStealer credential-stealing malware; a phishing technique abusing the special-use .arpa domain and IPv6 reverse DNS to evade email and domain-based defenses, using attacker-controlled DNS zones, traffic distribution systems, and lures like surveys and account notices; the "Zombie ZIP" technique that manipulates ZIP headers to bypass AV/EDR scanning, tied to CVE-2026-0866 and demonstrated to evade most VirusTotal engines; and a surge in pro-Iranian and pro-Russian hacktivist retaliation targeting Israel and regional entities with DDoS, defacements, breach claims, and disinformation, alongside Israel's humorous counter-psychological video response. Cybersecurity Today  would like to thank Meter for their support in bringing you this podcast. Meter delivers a complete networking stack, wired, wireless and cellular in one integrated solution that's built for performance and scale.  You can find them at Meter.com/cst 00:00 Sponsor Message Meter 00:19 Headlines And Intro 00:51 Fake Claude Install Scam 04:25 Arpa Domain Phishing 08:30 Zombie Zip Malware Trick 10:57 Cyber Retaliation Surge 13:44 Israel's PSYOP Video 14:25 Wrap Up And Sponsor

FBI investigates suspicious activities on agency network Over 100 GitHub repositories distributing BoryptGrab stealer Hackers abuse .arpa DNS and ipv6 to evade phishing defenses Get links to all the stories in our show notes: https://cisoseries.com/cybersecurity-news-fbi-network-breach-github-distributes-stealer-hackers-abuse-arpa/ Huge thanks to our sponsor, Dropzone AI Here is a number worth knowing before RSAC. The average enterprise SOC sees tens of thousands of alerts a day. Most get triaged. A fraction get thoroughly investigated. The rest sit in the queue or get auto-closed.   Dropzone AI puts AI SOC agents on every one of those alerts. Every alert investigated, end to end, across your full tool stack, around the clock. Over 300 deployments in production today.   They are at RSAC this year. Booth 455. dropzone.ai/rsa-2026-ai-diner  

"If a man isn't keeping his word to himself, he chips away at his trust in himself." A man's power begins and ends with his word. When he breaks financial commitments, delays payments he can afford, or hides behind pride instead of asking for help, he doesn't just damage relationships—he weakens himself. The real cost isn't legal or financial. It's internal. Self-trust erodes quietly, and once that foundation cracks, goals become fantasies instead of outcomes. Rob Arpa argues that masculine discipline shows up in the simplest places: paying bills, honoring agreements, and speaking up when things go wrong. Rob explains that fear of judgment keeps many men silent, but silence compounds the problem. When a man chooses addiction to comfort over integrity, he doesn't just hurt a contractor or business partner—he damages his own future momentum. Rob is the owner/operator of Green FX Landscaping, located in Etobicoke, Ontario. He's a veteran in the men's movement and a member of the Sovereign Man Iron Council. Learn more & connect: https://www.greenfxlandscaping.ca/ You're invited to come to a Sovereign Circle meeting to experience it for yourself. To learn more, go to https://www.sovereignman.ca/. While you're there, check out the Battle Ready program and check out the store for Sovereign Man t-shirts, hats, and books.

Four years after its founding, St. Louis' Office of Violence Prevention is still working to address the causes of violence — and trying to stop it before it happens. In November, the city named the office's new director, Marvin Teer, Jr. A former judge and prosecutor, Teer shares some of his experiences from three decades in the criminal justice system. He also addresses the likely impact of losing access to millions of dollars in federal funding when the American Rescue Plan Act expires at the end of the year. Teer says the change will affect more than 40 programs: “Our mission will go on,” he says, “but just in a very limited, or, at least in a reduced manner.” Joining Teer is James Watson, director of the nonprofit Show Me Peace, who discusses examples of how violence can be interrupted and how OVP creates an “ecosystem” of programs addressing its root causes.

Fake Fedex Email Delivers Donuts! https://isc.sans.edu/diary/Fake%20Fedex%20Email%20Delivers%20Donuts!/32754 Abusing .ARPA: The TLD that isn t supposed to host anything https://www.infoblox.com/blog/threat-intelligence/abusing-arpa-the-tld-that-isnt-supposed-to-host-anything/ MC1179154 - Microsoft Authenticator app: Upcoming changes to jailbreak and root detection https://mc.merill.net/message/MC1179154 SECURITY BULLETIN: Apex One and Apex One (Mac) - February 2026 https://success.trendmicro.com/en-US/solution/KA-0022458 Special Webcast: AirSnitch How Worried Should You Be? https://www.sans.org/webcasts/airsnitch-how-worried-should-you-be

Learn about the latest progress on the City of Murfreesboro's major stormwater initiative to daylight Town Creek through downtown on this new episode of “The Insider,” the official City of Murfreesboro podcast. In this episode, Development Services Executive Director Greg McKnight and Ryan Maloney of Griggs & Maloney Engineering and Consulting break down key updates on the multi‑year project, including: • The role of SBW Constructors, the primary contractor • What “urban stream restoration” means for the future of Town Creek • Installation of the new Front Street bridge • How this work connects to broader downtown redevelopment The $22 million, 18‑month Town Creek Project—funded in part by federal ARPA stimulus dollars—must be completed by November 2026, with a City deadline of Dec. 31, 2026. Maloney notes that contractors aim to complete and close out the stormwater‑funded portion by September 2026. Stay informed on one of Murfreesboro's most transformative infrastructure projects! Visit www.murfreesborotn.gov/towncreekproject for more information.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Desde la más remota antigüedad, las estructuras de poder han estado presenten en los diferentes grupos humanos desde las cuevas de Altamira hasta hoy. Esta realidad está presente en el libro del catedrático y emérito José Luis Villacañas, de la Universidad Complutense. Acaba de publicar el libro Senderos que se bifurcan (Arpa). Con él charlamos y escuchamos como si fuéramos sus alumnos.

Hablamos con la catedrática emérita de filosofía Victoria Camps, autora del libro “La sociedad de la desconfianza” (Arpa editorial) donde nos plantea cómo recuperar la confianza en un mundo donde se ha perdido la visión moral de la política y la vida cotidiana. Nos recibe la filósofa en su casa de Sant Cugat, una población cercana a Barcelona. Sobre la mesa un café que casi se nos olvida beber porque la conversación enseguida nos enreda a comentar el mal momento que estamos viviendo. La filosofía es más necesaria que nunca. Más necesaria que este primer café que se enfría. En un rato llegarán los hijos y los nietos a comer con ella, y ahí la filósofa da paso a la abuela que igual reflexiona sobre la condición humana preparando el sofrito.  

Peachtree Corners continues to push forward on what “smart city” can really mean—and in this in-person episode of Peachtree Corners Life, host Rico Figliolini sits down with City Councilman Phil Sadd (Post 1, District 1) to unpack the biggest initiatives shaping the city right now. From public safety innovation to trails, traffic, redevelopment, and housing, Phil walks through what's happening, why it matters, and what residents can expect next.Leading the conversation is a new Drone as First Responder pilot that can launch automatically from certain 911 priority calls—arriving on scene in seconds to provide real-time awareness, improve safety, and support de-escalation before officers arrive. The episode also covers major quality-of-life and economic development efforts including Crooked Creek Trail, workforce/affordable homeownership in Mechanicsville, updates on The Forum redevelopment, the new public innovation park Curiosity Corner, and upcoming mobility projects like the Peachtree Parkway lane conversion and the Winter's Chapel corridor multi-use path open house.Key takeawaysDrone as First Responder (DFR) is launching as a pilot with Brinc (integrated with Motorola's dispatch ecosystem), and Peachtree Corners is one of five partner cities—and the only one in Georgia.Crooked Creek Trail is a major long-term project (about 1.3 miles plus spurs) with heavy environmental and safety constraints due to waterway/EPA requirements; construction is still roughly two years out.Mechanicsville workforce homeownership plan uses ARPA funds for land acquisition (about five acres) and a public-private build model with price caps and anti-flip protections to keep homes affordable long-term.The Forum redevelopment is moving toward execution: Barnes & Noble relocation enables a 125-room boutique hotel on the corner; multifamily plans are updated to below 300 units, with parking decks designed to be visually screened by buildings; target start is early 2027 (funding-dependent).Curiosity Corner is a public innovation park in Technology Park with shaded seating + connectivity, plus testing for things like Pipedream underground delivery, drone delivery, and EV programs; projected completion this spring.Traffic improvement on Peachtree Parkway: converting an existing southbound turn lane into a third straight-through lane to reduce bottlenecks; funded via SPLOST with state permission.Winter's Chapel multi-use path (Phase 2) open house: joint city involvement due to corridor “zigzag” boundaries; open house is Feb 12, 5–7.Public safety discussion focuses on improving the county partnership: Phil emphasizes better communication, better data/metrics, a potential satellite office in Peachtree Corners, and addressing staffing shortages rather than rushing toward a new department vote.

Abrimos La Ventana de los libros para recibir a Luis Solano, editor de Libros del Asteroide, sello que ha publicado 'Hamnet' en lengua castellana, y a Joaquín Palau, editor de Arpa, en septiembre publicaron una nueva edición de 'Frankenstein o el moderno Prometeo' de Mary Shelley. Sigue el concurso de relatos para conocer al relato ganador de enero. Nieves Concostrina hace un nuevo repaso por la historia. Y por último, Isaías Lafuente repasa los mejores momentos del día. 

Ser Historia viaja al Museo Diocesano Regina Coeli de Santillana del Mar para disfrutar de la historia de una región absolutamente increíble. Comenzamos el cronovisor con Eduardo Palacio, conservador de las cuevas prehistóricas de Cantabria hablando de las teorías que se han presentado con más fuerza en las últimas décadas relacionando algunas pinturas rupestres con las estrellas. Luego nos visita Sara Izquierdo, alcaldesa de Santillana del Mar. Con ella descubrimos la belleza del patrimonio cultural de esta localidad cántabra. Pedro Ángel Fernández Vega, autor de Historia de Roma. Los orígenes (Ed. Arpa 2025), nos habla de los orígenes de la historia de Roma y la romanización. Acabamos el programa con Enrique Campuzano, director del Museo Diocesano quien nos pone en bandeja la historia de este lugar del siglo XVI y la riqueza arqueológica, artística y documental con que cuenta

Then, we transition to a panel led by Susan Stuart Clark featuring library directors Jayanti Addleman (Hayward) and Derek Wolfgram (Redwood City). They share on-the-ground stories of how their institutions transformed overnight—from providing hotspots and homework centers to becoming de facto daytime shelters for unhoused neighbors. This episode highlights the resilience of library staff, the mental health crisis, and the lasting impact of the digital divide.Key Topics & Takeaways[00:03:40] Origins of “Free for All”: How the filmmakers realized librarians are "first responders" during Hurricane Katrina, aiding evacuees when other systems failed.[00:10:45] The RV Tour Idea: Innovative distribution plans to project the documentary in library parking lots to maintain community during social distancing.[00:15:00] Hayward's Pivot: How Hayward Public Library immediately extended loan periods to one year and distributed hotspots to support students and immigrant families.[00:18:20] Redwood City Online: The surprise benefit of online programming, which increased accessibility for people with disabilities and transportation barriers.[00:21:00] Basic Needs & Hygiene: Libraries stepping up to provide portable toilets and handwashing stations for unhoused populations when public spaces closed.[00:30:00] The Heartbreak of Success: A story about a patron who found housing but was devastated to lose his daily connection to the Redwood City Library community.[00:50:00] The Future of Funding: The unprecedented opportunity of ARPA stimulus funds going directly to cities to help rebuild local services.Guests & HostGeorge Koster – Host and Executive Producer of Voices of the Community.Eric Estrada – Associate Producer and Host.Dawn Logsdon & Lucie Faulknor – Co-Founders of Serendipity Films and creators of the documentary Free for All.Susan Stuart Clark – Founder of Common Knowledge and community engagement expert.Jayanti Addleman – Director of Library Services for the City of Hayward.Derek Wolfgram – Library Director of Redwood City Public Library.Resources & Links MentionedFree for All Documentary: Learn more about the film at FreeForAllFilms.org.Voices of the Community Episode 10: Listen to the full interview with the filmmakers here: https://georgekoster.com/voc-free-for-allVoices of the Community Library Panel: Listen to the full panel discussion with Susan, Jayanti, and Derek here: https://georgekoster.com/voc-stories-common-knowledge-library-panelLearn More about our Guests & Series Listen to the full conversations: Dive deeper into these stories by listening to the complete interviews in Episode 10 and the Library Panel Episode.Explore the Series: Check out the full COVID-19 Special SeriesSupport the Show: Please consider making a tax-deductible donation to help us continue producing these stories. Click the donate button at voicesofthecommunity.comSignup for our Newsletter to stay in the loop on future shows and live eventsMake a Donation: Support Voices of the Community, fiscally sponsored by Intersection for the Arts, a 501(c)(3) nonprofit, and enjoy tax deductions for your contributions. Credits & AcknowledgmentsProduced by: George Koster and Alien Boy ProductionsAssociate Producer, Audio & Video: Eric EstradaVisual Design: Casey Nance of Citron StudioBroadcast Partners: KSFP-LP 102.5 FM (San Francisco) and KPCA-LP 103.3 FM (Petaluma)Special Thanks: BAVC Media for the initial collaboration on the SF Non-Profit Spotlight.TranscriptFull transcripts and video episodes are available on our website and YouTube channel.Website:https://georgekoster.com/voc-c19-highlight-show-part-4-libraries-transcriptYouTube: George Koster Delve deeper into the Voices of the Community Series on Arts & Culture, Making the Invisible Visible, Covid-19's impact on nonprofits, small enterprises and local government, the City of Stockton's rise from the ashes of bankruptcy, and our archives:You can explore episodes, speakers, organizations, and resources through each series web page. Watch and learn from all five series now!,

El escritor y periodista Fidel Moreno nos habla de El hombre equivocado en el momento oportuno (Ed. Pre-Textos), su primer poemario como tal, que es abono para el pensamiento crítico, el derecho a la duda y a la contradicción. Luego, Ignacio Elguero se asoma a los escaparates para recomendarnos varios libros: Albión (Ed. Libros del Asteroide), novela de la británica Anna Hope sobre la herencia y los privilegios de clase, Jorge Luis Borges. Un destino literario (Ed. Cátedra), biografía en la que el profesor Lucas Adur reinterpreta algunos episodios de la vida del escritor argentino a partir de los últimos documentos encontrados y A sangre y fuego. Héroes, bestias y mártires de España (Ed. Plataforma), reedición de la célebre colección de cuentos que Manuel Chaves Nogales escribió basándose en historias reales de la guerra civil española.Además, Javier Lostalé nos lee unos versos de En la hondura del tiempo, volumen que recoge treinta y siete poemas de la muy laureada escritora mexicana Coral Bracho en una cuidada edición de La Colección Péñola Blanca de la Fundación César Manrique.En su sección, Sergio C. Fanjul pone sobre la mesa Orfidal y Caballero (Ed. Arpa), libro en el que Ángeles Caballero baraja textos de corte periodístico con apuntes del natural, anécdotas de la vida e impresiones de todo tipo en las que saca partido a su ojo para el detalle y su desparpajo habitual.Terminamos el programa en compañía de Mariano Peyrou, que hoy pasa olímpicamente de las novedades para proponernos las obras de dos escritoras en neerlandés: la holandesa Albertina Soepboer, a la que leemos en una traducción del propio Peyrou, y la belga Charlotte van de Broek, de la que la editorial De Conatus publicó su libro Camaleón.Escuchar audio

Welcome to the latest episode of Carolina Cabinet! Host Peter Pappas is joined by intrepid reporter Myron Pitts and co-host Laura Musler for Cumberland County's smartest hour of talk radio. In this lively conversation, the trio digs into the pulse of Fayetteville's local politics, from election filings and the perennial drama at city council to candid reflections on voter turnout and the real impact of local government on our daily lives.You'll hear a refreshing dose of bipartisanship as Laura Musler and Myron Pitts examine what keeps local politics both passionate and pragmatic, debating everything from the transparency of ARPA funds to why potholes—and clean water—aren't partisan issues. Plus, they take on some big-picture topics like healthcare, the changing landscape of media, and the importance of community involvement, while keeping the conversation grounded in the issues that matter most to residents.If you've ever wondered about how decisions made at city council shape our future, or what really drives local political engagement, this episode is for you. Whether you're a longtime Fayetteville resident or just want smarter local talk, tune in to Carolina Cabinet for insight, wit, and a thoughtful look at the stories shaping our community.big-picture topics like healthcare, the changing media landscape